Clinical Trials List
2022-07-01 - 2024-03-31
Phase III
Recruiting3
Terminated1
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- MING-CHE LIU 無
- 陳宥達 無
- 王森德 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鄭鈞文 無
- 黃集仁 無
- Po-Yan Huang 無
- 謝顯森 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
123 participants
-
Global
2600 participants
